Menu Philippe 4

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold a total of 5,100 shares in two open-market transactions on April 6–7, 2026, generating approximately $24,773 in proceeds ($13,096 and $11,677). The trades were reported on a Form 4 filed April 8, 2026, and are coded as sales (S).

Key Details

• Transaction dates and reported weighted-average prices:
  • 2026-04-06: 2,700 shares sold; reported avg price $4.85 (range: $4.62–$4.95). (Footnote F2)
  • 2026-04-07: 2,400 shares sold; reported avg price $4.87 (range: $4.78–$4.98). (Footnote F3)
• Total shares sold: 5,100; total reported proceeds: $24,773 ($13,096 + $11,677).
• Reason/footnote: Sales were made to satisfy tax withholding obligations from RSU vesting on April 2 and 3, 2026, and were executed pursuant to a pre-established Rule 10b5-1 trading plan (Footnote F1) — not discretionary trades.
• Shares owned after the transactions: Not disclosed in the filing.
• Filing timeliness: Form 4 filed April 8, 2026; no late-filing indication in the report.

Context
These were tax-withholding sales tied to restricted stock unit vesting and executed under a 10b5-1 plan. Such routine withholding sales are generally considered administrative (not a directional bet on the stock). The filing notes weighted-average prices and provides price ranges; the reporting person offers to supply a per-price breakdown on request.